powerpoint presentation · rare diabetic ketoacidosis (may occur with no hypergtytemia). increased...

14

Upload: others

Post on 12-Nov-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 2: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 3: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 4: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 5: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy

Glucose’s effect on blood vessels

Page 6: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 7: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy

Cholesterol’s effect on blood vessels

Page 8: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy

Blood pressure’s effect on blood vessels

Page 9: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 10: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 11: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy

CARBOHYDRATE PROTEIN FAT

Increase blood glucose * No increase in blood glucose

Presenter
Presentation Notes
* With the exception of fibre
Page 12: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy

Metformin Liver: decreases glucose production

and release Tissues: increases usage of glucose

$

Linagliptin, Saxagliptin, Sitagliptin Prevents breakdown of natural incretin hormones Intestines, Pancreas, Liver (see glutides) $$$

Canagliflozin, Dapagliflozin, Empagliflozin Kidneys: excretes sugar through urine $$$

Dulaglutide, Liraglutide Semaglutide

(injectable) Mimics incretin hormones:

Intestines: slows digestion Pancreas: increases insulin

release after meals Liver: decreases glucose

production $$$$ Acarbose

Intestines: slows absorption of dietary carbohydrates $$

Gliclazide, Glyburide, Repaglinide Pancreas: Secretes extra insulin $-$$

Approximate Costs $=$25 per month or less $$=$50 per month $$$=$100 per month $$$$=$200 per month or more

Presenter
Presentation Notes
Brand names: Metformin: Glucophage Canagliflozin: Invokana, Dapagliflozin: Forxiga, Empagliflozin: Jardiance Liraglutide: Victoza, Dulaglutide: Trulicity, Semaglutide: Ozempic Gliclazide: Diamicron, Glyburide: Diabeta, Repaglinide: Gluconorm Acarbose: Glucobay Sitagliptin: Januvia, Saxagliptin: Onglyza, Linagliptin: Trajenta
Page 13: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy
Page 14: PowerPoint Presentation · Rare diabetic ketoacidosis (may occur with no hypergtytemia). Increased risk 01 fractures and amputations with canagliflozin Reduced progresirn nephropathy